Our finding on the expression of ACE2 and TMPRSS4 in lung cells enriched with malignant (adenocarcinoma) features may have implications for the management of COVID-19 in lung cancer, and clinical studies are warranted to explore this conjecture. The gene discussed is TMPRSS4; the disease is COVID-19.